KotsevaKWoodDDe BackerG. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil2009; 16: 121–137.
2.
KotsevaKWoodDDe BackerG. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European 7295 countries. Eur J Cardiovasc Prev Rehabil2010; 17: 530–540.
3.
ReinerZCatapanoALDe BackerG. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J2011; 32: 1769–1818.
4.
PerkJDe BackerGGohlkeH. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur J Prev Cardiol2012; 19: 585–667.
5.
GuyattGHOxmanADVistGE. GRADE: an emerging consensus on rating quality of evidence strength of recommendations. BMJ2008; 336: 924–926.
6.
ReinerŽ. New ESC/EAS Guidelines for the management of dyslipidaemias – any controversies behind the consensus?Eur J Cardiovasc Prev Rehabil2011; 18: 724–727.
